|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/30 | (2006.01) | ||
| C07K 16/46 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3331910 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16750150.1 |
| Date of filing the European patent application | 2016-08-03 | |
| (97) | Date of publication of the European application | 2018-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-11 |
| (46) | Date of publication of the claims translation | 2020-03-25 |
| (86) | Number | PCT/EP2016/068549 |
| Date | 2016-08-03 |
| (87) | Number | WO 2017/021450 |
| Date | 2017-02-09 |
| (30) | Number | Date | Country code |
| 15179549 | 2015-08-03 | EP |
| (72) |
VU, Minh, Diem, CH
STREIN, Klaus, DE
AST, Oliver, CH
BACAC, Marina, CH
DELON, Camille, CH
DUERNER, Lydia Jasmin, CH
FREIMOSER-GRUNDSCHOBER, Anne, CH
KLEIN, Christian, CH
MOESSNER, Ekkehard, CH
MOSER, Samuel, CH
UMANA, Pablo, CH
WEINZIERL, Tina, CH
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543-400,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Monokloniniai antikūnai prieš žmogaus B ląstelių brendimo antigeną (BCMA) |
| MONOCLONAL ANTIBODIES AGAINST HUMAN B CELL MATURATION ANTIGEN (BCMA) |
| Payment date | Validity (years) | Amount | |
| 2025-07-03 | 10 | 231.00 EUR |
| 2026-08-03 |